Annual report pursuant to Section 13 and 15(d)

Net Loss per Common Share (Tables)

v3.20.1
Net Loss per Common Share (Tables)
12 Months Ended
Dec. 31, 2019
Net Loss per Common Share  
Schedule of diluted weighted average shares outstanding

The following shares of potentially dilutive securities, weighted during the years ended December 31, 2019 and 2018 have been excluded from the computations of diluted weighted average shares outstanding as the effect of including such securities would be antidilutive:

 

 

 

 

 

 

 

 

For the Years Ended December 31,

 

    

2019

    

2018

Warrants to purchase Common Stock

 

849,186

 

886,682

Opus warrants to purchase Common Stock

 

1,880,000

 

1,880,000

Options to purchase Common Stock

 

1,179,680

 

1,085,502

Convertible preferred stock

 

1,038,251

 

1,000,000

Unvested Restricted Stock

 

12,625,144

 

11,174,113

Unvested Restricted Stock Units

 

721,478

 

1,655,849

Total

 

18,293,739

 

17,682,146